Overview
- 15 inspections across 15 sites are on record.
- 7 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2009-07-02.
At a glance
Inspections
15
Sites
15
Observations
7
Career since
Jun 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Aino Co., Ltd. of North China Pharmaceutical Group | 2 Jul 2009 | On file | |
| Hovione PharmaScience Limited | 24 Jun 2009 | On file | |
| Bora Pharmaceuticals Laboratories, Inc | 18 Jun 2009 | On file | |
| Ningxia Qiyuan Pharmaceutical Co Ltd | 6 May 2009 | On file | |
| Ningxia Qiyuan Pharmaceutical Co., Ltd. | 6 May 2009 | On file |
Sites inspected
Aino Co., Ltd. of North China Pharmaceutical GroupShijiazhuang, Hebei, China1 insp.
Hovione PharmaScience LimitedTaipa, Macao1 insp.
Bora Pharmaceuticals Laboratories, IncMiaoli County, Taiwan1 insp.
Ningxia Qiyuan Pharmaceutical Co LtdYinchuanshi, China1 insp.
Ningxia Qiyuan Pharmaceutical Co., Ltd.Yinchuan, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Chunchang Fang's 7 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site